References
- Kasper B, Salameh A, Krausch M, et al. Epigallocatechin gallate attenuates cardiopulmonary bypass-associated lung injury. J Surg Res. 2016;201(2):313–325.
- Ranucci M, Ballotta A, La Rovere MT, Castelvecchio S. Surgical, Clinical Outcome Research G. Postoperative hypoxia and length of intensive care unit stay after cardiac surgery: the underweight paradox? PloS One. 2014;9(4):e93992.
- Clark SC. Lung injury after cardiopulmonary bypass. Perfusion. 2006;21(4):225–228.
- Qi D, Gao MX, Yu Y. Intratracheal antitumor necrosis factor-alpha antibody attenuates lung tissue damage following cardiopulmonary bypass. Artif Organs. 2013;37(2):142–149.
- Zhang Z, Chen L, Ni H. The effectiveness of Corticosteroids on mortality in patients with acute respiratory distress syndrome or acute lung injury: a secondary analysis. Sci Rep. 2015;5:17654.
- Devasya A, Sarpangala M. Dexmedetomidine: a review of a newer sedative in dentistry. J Clin Pediatr Dent. 2015;39(5):401–409.
- Zhang W, Zhang JQ, Meng FM, Xue FS. Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1alpha signaling pathway. J Anesth. 2016;30(5):826–833.
- Li J, Chen Q, He X, et al. Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through alpha2AR/PI3K/Akt pathway. J Transl Med. 2018;16(1):78.
- Cheng C, Li S, Wang Y, Chen S, You L, Zhang H. Ischemic postconditioning alleviates lung injury and maintains a better expression of aquaporin-1 during cardiopulmonary bypass. Chin Med J (Engl). 2014;127(23):4012–4018.
- Zhang Z. Univariate description and bivariate statistical inference: the first step delving into data. Ann Transl Med. 2016;4(5):91.
- Yang K, Gao B, Wei W, et al. Changed profile of microRNAs in acute lung injury induced by cardio-pulmonary bypass and its mechanism involved with SIRT1. Int J Clin Exp Pathol. 2015;8(2):1104–1115.
- Yan X, Cheng X, Zhou L, He X, Zheng W, Chen H. Dexmedetomidine alleviates lipopolysaccharide-induced lung injury in Wistar rats. Oncotarget. 2017;8(27):44410–44417.
- Meng L, Li L, Lu S, et al. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. Mol Immunol. 2018;94:7–17.
- Herold S, Ludwig S, Pleschka S, Wolff T. Apoptosis signaling in influenza virus propagation, innate host defense, and lung injury. J Leukoc Biol. 2012;92(1):75–82.
- Eefting F, Rensing B, Wigman J, et al. Role of apoptosis in reperfusion injury. Cardiovasc Res. 2004;61(3):414–426.
- Liu C, Yang J, Fu W, et al. Coactivation of the PI3K/Akt and ERK signaling pathways in PCB153-induced NF-κB activation and caspase inhibition . Toxicol Appl Pharmacol. 2014;277(3):270–278.
- Martini M, De Santis MC, Braccini L, Gulluni F, Hirsch E. PI3K/AKT signaling pathway and cancer: an updated review. Ann Med. 2014;46(6):372–383.
- Yu H, Littlewood T, Bennett M. Akt isoforms in vascular disease. Vasc Pharmacol. 2015;71:57–64.
- Tsuchiya A, Kanno T, Nishizaki T. PI3 kinase directly phosphorylates Akt1/2 at Ser473/474 in the insulin signal transduction pathway. J Endocrinol. 2014;220(1):49–59.
- Risso G, Blaustein M, Pozzi B, Mammi P, Srebrow A. Akt/PKB: one kinase, many modifications. Biochem J. 2015;468(2):203–214.
- Markou T, Chambers DJ. Lung injury after simulated cardiopulmonary bypass in an isolated perfused rat lung preparation: role of mitogen-activated protein kinase/Akt signaling and the effects of theophylline. J Thorac Cardiovasc Surg. 2014;148(5):2335–2344.